THC BioMed Announces Health Canada Licence of Three New Rooms at Acland Rd. Facility
THC BioMed Intl Ltd announced an amendment to its Health Canada License, allowing the addition of three new strata units at its Acland Road facility. These units include a storage area for edibles and dedicated production rooms for edibles, such as baked goods. Founded in 2013, THC BioMed aims to lead the beverage and edible cannabis sector, being a licensed producer of various cannabis products including dried and topical forms. The company has emphasized its commitment to research and development in the rapidly growing cannabis market.
- Health Canada License amended to add 3 new strata units for production and storage.
- Expansion supports growth in the beverage and edible cannabis market.
- None.
THC.CSE
THCBF - OTC
TFHD.F
VANCOUVER, BC, July 14, 2021 /PRNewswire/ - THC BioMed Intl Ltd. ("THC BioMed" or the "Company" is pleased to announced that its Health Canada Licence has been amended to include 3 additional strata units at its Acland road location. The 3 strata units include a new storage area for edibles as well as production rooms for edibles, including baked goods.
About THC
THC BioMed is one of Canada's oldest active licensed cannabis companies. It was first licensed to deal with cannabis in 2013 under a Health Canada Section 56 exemption under the Controlled Drugs and Substances Act and has been a Licensed Producer under the current regime since 2016. It aims to be a leader in the beverage and edible space.
THC BioMed is a Cannabis Act Licensed Producer of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. The Company is on the leading edge of scientific research and the development of products and services in the medical and recreational cannabis industry. Management believes THC BioMed is well-positioned to be in the forefront of this rapidly growing industry.
Forward-Looking Information:
This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of THC BioMed. Forward-looking information is based on certain key expectations and assumptions made by the management of THC BioMed. In some cases, you can identify forward-looking statements using words such as "will," "may," "would," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "could" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Forward-looking statements in this release are made as of the date of this press release and include that THC BioMed will be on the forefront of this rapidly growing industry. Although THC BioMed believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because THC BioMed can give no assurance that they will prove to be correct. THC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.
View original content to download multimedia:https://www.prnewswire.com/news-releases/thc-biomed-announces-health-canada-licence-of-three-new-rooms-at-acland-rd-facility-301333227.html
SOURCE THC BioMed
FAQ
What recent changes did THC BioMed make to its Health Canada License?
How does THC BioMed plan to grow its edibles segment?
When was THC BioMed founded?
What types of cannabis products can THC BioMed produce?
What is THC BioMed's focus in the cannabis sector?
